Table 3.
Diagnoses of 411 referred lesions: 176 in best practice (control) group and 235 in MoleMate (intervention) group*
| Reference standard diagnosis | Appropriately referred | Not appropriately referred | |||||
|---|---|---|---|---|---|---|---|
| Control group | Intervention group | Total | Control group | Intervention group | Total | ||
| Total | 111 | 130 | 241 | 61 | 99 | 160 | |
| Method of diagnosis†: | |||||||
| Histology | 100 | 115 | 215 | — | — | — | |
| Monitored | 9 | 13 | 22 | — | — | — | |
| Expert | — | — | — | 61 | 99 | 160 | |
| Melanoma‡: | 17 | 18 | 35 | ||||
| Superficial spreading | 12 | 11 | 23 | — | — | — | |
| Nodular | 0 | 2 | 2 | — | — | — | |
| Lentigo maligna melanoma | 3 | 1 | 4 | — | — | — | |
| In situ§ or lentigo maligna | 2 | 4 | 6 | — | — | — | |
| Other skin cancers: | 1 | 5 | 6 | ||||
| Squamous cell carcinoma | 0 | 1 | 1 | — | — | — | |
| Basal cell carcinoma | 1 | 4 | 5 | — | — | — | |
| Other lesions: | 82 | 92 | 174 | 61 | 99 | 160 | |
| Dysplastic (atypical) naevus | 26 | 31 | 57 | 2 | 6 | 8 | |
| Seborrhoeic keratosis | 8 | 14 | 22 | 12 | 31 | 43 | |
| Dermatofibroma and haemangioma | 0 | 3 | 3 | 2 | 6 | 8 | |
| Lentigo | 5 | 4 | 9 | 0 | 1 | 1 | |
| Other benign¶ | 43 | 40 | 83 | 45 | 55 | 100 | |
*Participants totalling 10 referred lesions did not attend for dermatology assessment (four in control group, six in intervention group).
†Missing histology (two in control group, two in intervention group).
‡Invasive and pre-invasive.
§Clark level 1.
¶For example, benign naevus.